Jim Cramer Notes Tempus AI is "Losing Money Hand Over Fist"

Tempus AI, Inc. (NASDAQ:TEM) is one of the stocks on Jim Cramer’s radar. Answering a caller’s query about the company during the lightning round, Cramer said:

“Okay, another company that’s just losing money hand over fist. I just can’t go there. You know, when it comes to AI, you know what I believe in? I believe in NVIDIA.”

Tempus AI (NASDAQ:TEM) provides advanced healthcare technology solutions, including molecular diagnostics, data analytics platforms, and clinical trial matching services for the medical and life sciences sectors. The company’s solutions support diagnostics, research, and oncology programs through tools like Insights, Lens, and Algos. A couple of months ago, when a caller inquired about the company, Cramer replied:

“Yeah, diagnostics with no money being made. We’re not recommending stocks right now that are losing a lot of money because we think this could be a dicey environment, but [could] turn on a dime, that it’s going to go fine right now, but I don’t like companies that aren’t making any money.”

While we acknowledge the potential of TEM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.